Innovative drug concept stocks rapidly plummeted, with NEPTUNUS hitting the daily limit, RemeGen falling more than 10%, and many stocks including Cosunter, Rundu Pharma, Sunshine Guojian Pharmaceutical, SL PHARM, and HITECK dropping more than 6%Wallstreetcn·Apr 6 at 08:41 PM512290-0.69%002038-2.00%
National Healthcare Security Administration: Key drug "Deferasirox" for treating "thalassemia" included in medical insurance36Kr·Jan 30 at 08:39 PM002038-2.00%512290-0.69%
SL PHARM: GLP-1 long-acting products are organizing materials in preparation for reportingZhitong·Nov 2, 2025 at 07:17 PM002038-2.00%
SL PHARM released its performance for the first three quarters, with a net profit attributable to the parent company of 141 million yuan, a year-on-year increase of 943.10%Zhitong·Oct 26, 2025 at 06:50 AM002038-2.00%
SL PHARM: The invested company Changfeng Pharmaceutical plans to go public in Hong Kong on October 8Zhitong·Sep 30, 2025 at 02:45 AM002038-2.00%
SL PHARM: Liang Shujie plans to reduce her holdings by 0.0365%Zhitong·Sep 17, 2025 at 07:50 AM002038-2.00%
SL PHARM released its performance for the first half of the year, with a net profit attributable to the parent company of 121 million yuan, an increase of 309.08%Zhitong·Aug 25, 2025 at 10:02 AM002038-2.00%
SL PHARM: Expected net profit in the first half of the year to increase by 237.95%-356.24% year-on-yearZhitong·Jul 11, 2025 at 05:58 AM002038-2.00%
Xinghao Pharmaceutical: SL PHARM plans to reduce its holdings of no more than 1.51% of the company's sharesZhitong·Jun 3, 2025 at 05:56 AM002038-2.00%
SL PHARM released its first-quarter performance, with a net profit attributable to the parent company of 45.9684 million yuan, a year-on-year decrease of 34.46%Zhitong·Apr 21, 2025 at 11:11 AM002038-2.00%
SL PHARM: Net profit loss of 74.0657 million yuan in 2024Zhitong·Apr 21, 2025 at 07:46 AM002038-2.00%
SL PHARM has obtained the drug registration certificate for nitroglycerin sprayZhitong·Apr 8, 2025 at 03:53 AM002038-2.00%
SL PHARM has obtained the drug registration certificate for Regofenib tabletsZhitong·Apr 1, 2025 at 03:44 AM002038-2.00%
SL PHARM: Downgraded performance expectations，预计 losses of 73 million to 95 million yuan in 2024Zhitong·Mar 26, 2025 at 06:37 AM002038-2.00%
SL PHARM has obtained the drug registration certificate for Telmisartan and Amlodipine Tablets (II)Zhitong·Mar 14, 2025 at 04:38 AM002038-2.00%
